• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Roche Holding AG Basel American Depositary Shares (OP:RHHBY)

38.84 -0.07 (-0.18%)
Streaming Delayed Price Updated: 3:59 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,275,090
Open 37.85
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 38.91
Today's Range 37.70 - 38.95
52wk Range 34.10 - 44.31
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Genentech’s Susvimo Maintains Vision Over Five Years With Two Refills Per Year in People With Wet Age-Related Macular Degeneration (AMD)
August 01, 2025
From Genentech
Via Business Wire
FDA Probes Death Of 8-Year-Old Who Received Sarepta's Elevidys
July 28, 2025
FDA probes Elevidys after an 8-year-old's death in Brazil; Sarepta and Roche say the death was unrelated to gene therapy treatment. 
Via Benzinga

Performance

YTD
+11.2%
+11.2%
1 Month
-4.0%
-4.0%
3 Month
-6.0%
-6.0%
6 Month
-1.2%
-1.2%
1 Year
-4.6%
-4.6%

More News

Read More
Genentech and Roche Present New Insights in Alzheimer’s Disease Research Across Its Diagnostics and Pharmaceutical Portfolios at AAIC
July 28, 2025
From Genentech
Via Business Wire
Roche Bets Big On Alzheimer’s Prevention With New Trial As Duchenne Drug Setback Looms
July 27, 2025
Via Stocktwits
The Median Retirement Savings for American Households Is $87,000. Here Are 3 Incredible Stocks to Buy Now and Hold for Decades.
July 26, 2025
Via The Motley Fool
Topics Artificial Intelligence Retirement
Sarepta Gets Thumbs Down From Regulators Regarding Elevidys Gene Therapy
July 25, 2025
Via Benzinga
Sarepta Stock Slumps After EU Regulator Recommends Refusing Approval To Its Contentious Gene Therapy: Retail Expects Stock Bounceback
July 25, 2025
Via Stocktwits
Topics Death
Abivax Hits The Stratosphere, Up 500%, On 'Potentially Disruptive' Results
July 23, 2025
Via Investor's Business Daily
Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US
July 22, 2025
Via Benzinga
Topics Government
Genentech Provides Update on Astegolimab in Chronic Obstructive Pulmonary Disease
July 21, 2025
From Genentech
Via Business Wire
Genentech Provides Update on Supplemental Biologics License Application for Columvi Combination for People With Relapsed or Refractory Diffuse Large B-cell Lymphoma
July 18, 2025
From Genentech
Via Business Wire
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains'
July 16, 2025
Via Benzinga
Topics Government World Trade
Magnificent 7 Crush EU Giants—Jamie Dimon Tells Europe: 'You're Losing'
July 11, 2025
Via Benzinga
Options Corner: Bullish Traders Eye Eli Lilly As Market Signals Hint At A Turnaround
July 07, 2025
Via Benzinga
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
July 07, 2025
Via Investor Brand Network
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
July 07, 2025
Via FinancialNewsMedia
Topics Death
Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment?
June 30, 2025
Via Investor's Business Daily
Trump Vows To Cut 'The Best Deal' On Drug Prices. What To Expect.
June 26, 2025
Via Investor's Business Daily
Topics Government
Can Biogen Outdo Its Own Spinal Muscular Atrophy Drug?
June 25, 2025
Via Investor's Business Daily
Analyst Flags Septerna As Undervalued Biotech Play With Significant Upside
June 23, 2025
Via Benzinga
Exelixis' Zanzalintinib Combo Boosts Survival In Colorectal Cancer, Stock Soars
June 23, 2025
Via Benzinga
Exelixis Catapults 14% On Positive Results For Next-Gen Colon Cancer Drug
June 23, 2025
Via Investor's Business Daily
Two Biotech Stocks Poised For Big Moves On Monday
June 23, 2025
Via Benzinga
Genentech’s Lunsumio and Polivy Combination Significantly Prolongs Remission for People With Relapsed or Refractory Large B-cell Lymphoma
June 20, 2025
From Genentech
Via Business Wire
MAIA’s New Agreement With Big Pharma Roche Turns Retail Investors Bullish As Stock Soars
June 18, 2025
Via Stocktwits

Frequently Asked Questions

Is Roche Holding AG Basel American Depositary Shares publicly traded?
Yes, Roche Holding AG Basel American Depositary Shares is publicly traded.
What exchange does Roche Holding AG Basel American Depositary Shares trade on?
Roche Holding AG Basel American Depositary Shares trades on the OTC Traded
What is the ticker symbol for Roche Holding AG Basel American Depositary Shares?
The ticker symbol for Roche Holding AG Basel American Depositary Shares is RHHBY on the OTC Traded
What is the current price of Roche Holding AG Basel American Depositary Shares?
The current price of Roche Holding AG Basel American Depositary Shares is 38.84
When was Roche Holding AG Basel American Depositary Shares last traded?
The last trade of Roche Holding AG Basel American Depositary Shares was at 08/01/25 03:59 PM ET
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap